Hi-Risk/Recurrent/Advanced PrCa Video Chat, Oct. 19, 2026

Hi-Risk/Recurrent/Advanced PrCa Video Chat, Oct. 19, 2026

by | Oct 20, 2026 | Cancer Resources, Exercise, High Risk/Recurrent/Advanced, High Risk/Recurrent/Advanced Prostate Cancer, MedaFit, mHSPC, Prostate Cancer, Recorded Groups, Uncategorized

Hi-Risk/Recurrent/Advanced PrCa Video Chat, Oct. 19, 2026

 

AnCan IS ON SUBSTACK… find us at https://ancanspeak.substack.com/. Please sign up. We’re posting the best of all our Reminders.

AnCan thanks the following sponsors for making this recording possible: Novartis, Telix and Blue Earth Diagnostics.
Views expressed in this Recording are solely the opinion of AnCan Foundation, our Moderators and Participants.

AnCan does not accept sponsored promotion. Any drugs, protocols or devices discussed are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.

AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download

All AnCan’s groups are free and drop-in … join us in person sometime! You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/ Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/

Join our other free and drop in groups:
Men (Only) Speaking Freely…1st & 3rd Thursdays @ 8.00 pm Eastern https://ancan.org/men-speaking-freely/
Veterans Healthcare Navigation… 1st & 3rd Tuesdays @ 8.00 pm Eastern Schmier Room https://ancan.org/veterans/
Veterans Speaking freely… 4th Tuesday @ @ 8.00 pm Eastern Schmier Room

Editor’s Pick:  E2 doublet discussion – closely followed by integrating psilocybin into HT doublet!

Topics Discussed

Newbie diagnosed 4 years back with PSA @ 4000 & BRCA+ might consider a different doublet -or PARP; Newbie responds but has 4 consecutive negative PSMA scans – consider Axumin; could E2 doublet be an option?; PTEN just indicated; 2 negative Bx confirm our hunch Gent is Mx ; can experienced user integrate psilocybin into his HT to treat depression; monotherapy daro works exceptionally well – but must make decision on ‘Long Game’ trial; how long to stay on mono daro?; 1st Pluvicto rings PSA down a little – what to expect next?; Dr. Guancial uses fewer tests making Gent anxious – T/W her!

Chat

  • rick davsi sent: 5:49 PM

    Genetic Counseling for Families w. an Inherited Mutation https://ancan.org/8-31-2026-genetic-counseling-for-families-touched-by-an-inherited-germline-mutation-webinar/

  • John A sent: 6:01 PM

    Dr Eleni Efstathiou

  • Danny Lankford sent: 6:33 PM

    I want to ask Dr A if I can do the psilocybin therapy again while receiving radiation

  • Bob Schwartz, USN, Venice, FL. sent: 6:33 PM

    Danny, we’re all here for you brother.

  • Gary Martin sent: 6:42 PM

    RT can impact bone marrow–lowering blood counts and possibly increasing fatigue. This happened to me–lowering blood counts further to below-normal–on top of impact of triplet prior to RT.

    Read that ice packs have been shown to limit the effects of Pluvicto on salivary glands–study in Europe. Don’t have a reference to study yet.

  • Hank Zajic Springfield VA sent: 7:10 PM

    Good night all. Thank you for the discussion. out of battery here. Hank

  • Peter M sent: 7:12 PM

    Good night gents. Great meeting!

  • “Thomas” Matica sent: 7:19 PM

    Good night, everyone.

  • Frank Ciambra sent: 7:25 PM

    Good night everyone

AnCan Keynote at Houston Methodist, Aug 2024 – Can you hear us? Amplifying the patient voice.

AnCan Keynote at Houston Methodist, Aug 2024 – Can you hear us? Amplifying the patient voice.

by | Mar 25, 2026 | Advocacy, Blood Cancers, Cancer Caregivers, Cancer Resources, High Risk/Recurrent/Advanced Prostate Cancer, Low/Intermediate Prostate Cancer, MedaFit, Men 'Speaking Freely', Multiple Sclerosis, Ovarian Cancer, Pancreatic Cancer, Prostate Cancer, Uncategorized, Visual Snow Syndrome, Webinars

AnCan Keynote at Houston Methodist, Aug 2024 – Can you hear us? Amplifying the patient voice.

Can You Hear Us??       How AnCan helps patients make their voice heard – amplifying the patient voice!
Rick Davis gives keynote address at Houston Methodist Neal Cancer Center 12th Annual Cancer Symposium. August 2024.
Click  https://youtu.be/wCQlHIzKoA0-
Dr. B.J. Miller’s Prognosis Declaration Can Revolutionize the Quality of Your Treatment Path

Dr. B.J. Miller’s Prognosis Declaration Can Revolutionize the Quality of Your Treatment Path

by | Feb 10, 2021 | Advocacy, Blood Cancers, Brain Tumors, Cancer Caregivers, Cancer Resources, Health Resources, hospice and palliative, Maui, mCRPC, MedaFit, Men 'Speaking Freely', Men's Breast Cancer, Multiple Sclerosis, nmCRPC, Nutrition, Ovarian Cancer, Prostate Cancer, Recent News, RMC, Sarcoidosis, Thyroid Cancer, Webinars, Women's Breast Cancer

Dr. B.J. Miller’s Prognosis Declaration Can Revolutionize the Quality of Your Treatment Path

One of the most compassionate, influential and remarkable docs I have had the great fortune to encounter since I got into this biz, is Dr. BJ Miller. We are honored to have BJ on our Advisory Board, and while we rarely speak live, I consider him a friend.

More significantly,  a couple of men lost to this disease who I have known well, welcomed BJ to their medical teams …. and he made a huge difference to them. In a recent webiinar “Making Medical Decisions”, BJ shared a revolutionary document with us  ….BJ’s Prognosis+Declaration

All too often medical teams put their foot in their mouth …. and sometimes unwittingly yours, when they provide an unrequested prognosis for your situation. Some may want to know how serious their disease is .. or how long they have to live; others frequenbtly do not. The Prognosis Declaration offers four (4) options from knowing everything to knowing nothing, or maybe having your caregiver know but not you. You determine what you want to hear, and you give the Prognosis Declaration to your medical team upfront ….. brilliant! The form was developed by one of BJ’s patients who lost his wife to cancer.

The whole webinar, Managing Your Medical Decisons, can be heard here – it’s truly worth a listen.

Dr. Miller, btw, now runs his own non-profit organization The Center for Dying and Living. For many years he has been on the clinical and teaching faculty at UCSF. BJ’s remarkable TED Talk, ” What Really Matters At THe End of Life” now boasts over 12 million views.

Evidence that vigorous exercise may alter the course of prostate cancer

Evidence that vigorous exercise may alter the course of prostate cancer

by | May 31, 2019 | Exercise, Cancer Resources, MedaFit, Prostate Cancer, Recent News

AnCan and MedaFit have long been aggressive proponents of the importance of exercise to manage cancer, and in particular prostate cancer.

This short interview between one of AnCan’s favorite GU med oncs, Alicia Morgans at Northwestern and Lorelei Mucci ScD at Harvard examines a recent epidemiological study using the 50,000 male healthcare professionals cohort over 30 years. It finds that amongst the 6,000 men who contracted prostate cancer, those with advanced PCa who engaged in 25 minutes of VIGOROUS (heavy aerobic) exercise daily had a 30% lower risk of developing lethal prostate cancer. Moderate exercise did not show the same results.

MedaFit has been pushing this hypothesis going back to 2007 and is proud to be one of the catalysts bringing about greater academic study of exercise and prostate cancer.